Skip to content
Screener

Parker-Hannifin PH Pre-production expens incurred in connection with research and development contracts

Pre-production expens incurred in connection with research and development contracts at other companies

Walt Disney logo
Walt DisneyDIS
$377M-33.6%
Walt Disney logo
Walt DisneyDIS
$62M-65.9%
Walt Disney logo
Walt DisneyDIS
$315M-18.4%
Vor Biopharma logo
Vor BiopharmaVOR
$44.34M—
Beam Therapeutics logo
Beam TherapeuticsBEAM
$30.08M-12.6%
ADMA Biologics logo
ADMA BiologicsADMA
$0—

Other financials

Income statement

See full
Revenue$5.8B+9.8%
Gross profit$2.2B+14.8%
Net income$1.1B+18.2%
EPS (diluted)$8.54+19.4%

Balance sheet

See full
Cash & equivalents$501.0M+7.3%
Total debt$9.9B+19.4%
Total equity$15.4B+12.6%
Total assets$30.9B+4.7%

Cash flow

See full
Operating cash flow$1.7B+18.3%
CapEx$173.0M+32.1%
Free cash flow$1.6B+17.0%

Valuation

See full
Market cap$133.71B+43.2%
P/E36.7×+10.2×
P/S6.2×+1.5×

Profitability

See full
Gross margin37.7%+0.8pp
Net margin17%-0.8pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity25.1%-2.3pp
Debt / equity0.7×+0.1×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Parker-Hannifin in its filing.

Tagged under the XBRL concept ph:PreproductionCostsRelatedToResearchAndDevelopmentArrangement.

The source filing: Parker-Hannifin’s 10-K, filed August 22, 2025.

Filed
Aug 22, 2025
Fiscal year
FY2025
Accession
0000076334-25-000035

Independent research and development costs amounted to $240 million in 2025, $253 million in 2024 and $258 million in 2023. Pre-production expense incurred in connection with development contracts amounted to $58 million in 2025, $45 million in 2024 and $73 million in 2023.

ITEM 8. Financial Statements and Supplementary Data.

FAQ

What is Parker-Hannifin's pre-production expens incurred in connection with research and development contracts?
Parker-Hannifin (PH) reported pre-production expens incurred in connection with research and development contracts of $58M in Q2 2025.
What is the long-term trend for Parker-Hannifin's pre-production expens incurred in connection with research and development contracts?
Over 4 years (2021 to 2025), Parker-Hannifin's pre-production expens incurred in connection with research and development contracts has grown at a 1.8% compound annual growth rate (CAGR), from $54M to $58M.
What does pre-production expens incurred in connection with research and development contracts mean?
These are costs incurred in the development phase of new products or technologies prior to the commencement of commercial production, specifically associated with research and development contracts. These costs are often deferred or capitalized if they meet specific accounting criteria for future economic benefit. They represent the investment intensity in innovation and new product pipelines.

Ask your AI about Parker-Hannifin's pre-production expens incurred in connection with research and development contracts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude